flurazepam has been researched along with Sleep Initiation and Maintenance Disorders in 138 studies
Flurazepam: A benzodiazepine derivative used mainly as a hypnotic.
flurazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a 2-(diethylamino)ethyl group, 2-fluorophenyl group and chloro group at positions 1, 5 and 7, respectively. It is a partial agonist of GABAA receptors and used for the treatment of insomnia.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
Excerpt | Relevance | Reference |
---|---|---|
"This article contains the sleep results of the efficacy study of flurazepam 30 mg and 15 mg, midazolam 15 mg, and placebo in the 99 chronic insomniacs studied as part of this multicenter study." | 9.06 | Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. ( Ancoli-Israel, S; Hauri, P; Kripke, DF; Roth, T, 1990) |
"Four skills performance (psychomotor) tasks, including simple and choice reaction time, divided attention, and vigilance, were given to 99 chronic insomniacs to determine whether the use of midazolam 15 mg, or of flurazepam 15 or 30 mg, compared with placebo would produce next-day impairment throughout a 14-day treatment period." | 9.06 | Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam. ( Linnoila, M; Moskowitz, H; Roehrs, T, 1990) |
"Methods are described for a five-center study of flurazepam and midazolam, in which 107 patients with histories of benzodiazepine use for chronic insomnia were enrolled." | 9.06 | Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: methodology. ( Chernik, DA; Johnson, LC; Kanitra, L, 1990) |
"The 99 chronic insomniacs examined in the present multicenter study were given three cognitive tasks (reading comprehension, addition, and digit symbol substitution test [DSST]) as well as the Hopkins Symptom Checklist (HSCL) and the Profile of Mood States (POMS) in order to evaluate the effects of flurazepam (Dalmane) 15 and 30 mg, midazolam 15 mg, and placebo on cognitive performance and mood." | 9.06 | Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam. ( Ellinwood, E; Judd, LL; McAdams, LA, 1990) |
"Hypnotic efficacy and safety of 3 weeks of daily doses of 2 mg lorazepam or 30 mg flurazepam were compared in a double-blind cross-over study in eight chronic insomniacs between the ages of 29 and 60 years." | 9.06 | Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. ( Chang, H; McClure, DJ; Olah, A; Pecknold, JC; Walsh, J; Wilson, R, 1988) |
" Oxazepam and flurazepam were effective in improving some polysomnographically defined measures of nocturnal sleep in 14 patients with chronic insomnia; flurazepam produced substantial daytime sleepiness and oxazepam did not." | 9.05 | Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia. ( Bliwise, D; Dement, W; Greenblatt, DJ; Seidel, W, 1984) |
" No marked adverse reactions were found in any area for any group." | 6.67 | Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs. ( Hauri, P; Kripke, D; Roehrs, T; Sateia, MJ, 1990) |
"One hundred seven chronic insomniacs (41 men, 66 women; mean age, 37." | 6.67 | Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam. ( Judd, LL; Linnoila, M; Roehrs, T; Roth, T, 1990) |
"Three groups of ten middle-aged insomniac patients were treated with placebo, flurazepam, or zopiclone for 12 consecutive days in a study designed to compare the residual daytime effects of long-acting flurazepam and short-acting zopiclone on a variety of cognitive and motor tasks." | 6.66 | Effects of flurazepam and zopiclone on the performance of chronic insomniac patients: a study of ethanol-drug interaction. ( Buck, L; Csima, A; Mamelak, M; Price, V; Smiley, A, 1987) |
"This article contains the sleep results of the efficacy study of flurazepam 30 mg and 15 mg, midazolam 15 mg, and placebo in the 99 chronic insomniacs studied as part of this multicenter study." | 5.06 | Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam. ( Ancoli-Israel, S; Hauri, P; Kripke, DF; Roth, T, 1990) |
"25 mg of brotizolam, 15 mg of flurazepam, and placebo on the sleep and performance of elderly subjects with chronic insomnia during a 2-week period of administration." | 5.06 | A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. ( Buck, L; Csima, A; Mamelak, M; Price, V, 1989) |
"Methods are described for a five-center study of flurazepam and midazolam, in which 107 patients with histories of benzodiazepine use for chronic insomnia were enrolled." | 5.06 | Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: methodology. ( Chernik, DA; Johnson, LC; Kanitra, L, 1990) |
"Four skills performance (psychomotor) tasks, including simple and choice reaction time, divided attention, and vigilance, were given to 99 chronic insomniacs to determine whether the use of midazolam 15 mg, or of flurazepam 15 or 30 mg, compared with placebo would produce next-day impairment throughout a 14-day treatment period." | 5.06 | Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam. ( Linnoila, M; Moskowitz, H; Roehrs, T, 1990) |
"The 99 chronic insomniacs examined in the present multicenter study were given three cognitive tasks (reading comprehension, addition, and digit symbol substitution test [DSST]) as well as the Hopkins Symptom Checklist (HSCL) and the Profile of Mood States (POMS) in order to evaluate the effects of flurazepam (Dalmane) 15 and 30 mg, midazolam 15 mg, and placebo on cognitive performance and mood." | 5.06 | Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam. ( Ellinwood, E; Judd, LL; McAdams, LA, 1990) |
"Hypnotic efficacy and safety of 3 weeks of daily doses of 2 mg lorazepam or 30 mg flurazepam were compared in a double-blind cross-over study in eight chronic insomniacs between the ages of 29 and 60 years." | 5.06 | Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs. ( Chang, H; McClure, DJ; Olah, A; Pecknold, JC; Walsh, J; Wilson, R, 1988) |
"The hypnotic effects of l-tryptophan (1 g), secobarbital (100 mg), and flurazepam (30 mg), relative to placebo, were evaluated in a sample of 54 outpatient chronic insomniacs with a major complaint of sleep maintenance insomnia." | 5.05 | Selectivity in response to L-tryptophan among insomniac subjects: a preliminary report. ( Hartmann, EL; Lindsley, JG; Mitchell, W, 1983) |
" Oxazepam and flurazepam were effective in improving some polysomnographically defined measures of nocturnal sleep in 14 patients with chronic insomnia; flurazepam produced substantial daytime sleepiness and oxazepam did not." | 5.05 | Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia. ( Bliwise, D; Dement, W; Greenblatt, DJ; Seidel, W, 1984) |
"Eleven patients suffering from chronic insomnia were given 30 mg flurazepam for 28 nights." | 5.05 | A clinical study of flurazepam. ( Garnett, D; Gillin, JC; Greenblatt, DJ; Mendelson, WB; Weingartner, H, 1982) |
"Twelve volunteers with a complaint of chronic insomnia participated in a placebo-controlled, double-blind, crossover study of the effects of buspirone t." | 5.05 | Buspirone: an anxiolytic without sedative effect. ( Bliwise, NG; Cohen, SA; Dement, WC; Seidel, WF, 1985) |
"6 mg) or flurazepam (30 mg) was given to chronic insomniac patients for 7 consecutive nights in parallel, double-blind design." | 5.04 | Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepam. ( Lasagna, L; Sundaresan, PR; Wardell, WM; Weintraub, M, 1979) |
"A male patient with chronic insomnia experienced withdrawal symptoms when flurazepam (30 mg h." | 3.66 | Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: a case report. ( Berlin, RM; Conell, LJ, 1983) |
"Participants with chronic insomnia (N = 53), completed 2 baseline weeks of sleep diaries, and were randomly assigned to a treatment group for 2 more weeks." | 2.71 | Behavioral and hypnotic treatments for insomnia subtypes. ( Anderson, T; Betz, B; Binks, PG; Carney, CE; Fuller, KH; Hurry, MJ; Johnson, J; Lajos, LE; Tucci, JM; Waters, WF, 2003) |
"In contrast to previous reports with insomniacs, both compounds made only modest improvements in sleep." | 2.68 | Effects of flurazepam and zolpidem on the perception of sleep in normal volunteers. ( Mendelson, WB, 1995) |
"Sixty insomniac patients participated in a controlled double-blind parallel group study designed to investigate the dose-response relationship of zopiclone." | 2.67 | A dose-range finding study of zopiclone in insomniac patients. ( Dimitri, R; Le Morvan, P; Nair, NP; Schwartz, G; Thavundayil, JX, 1990) |
"Outpatients complaining of insomnia were randomized to receive either estazolam 2 mg, flurazepam 30 mg or placebo for 7 consecutive nights." | 2.67 | Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia. ( Dominguez, RA; Roth, PB; Scharf, MB; Ware, JC, 1990) |
"Estazolam is a new benzodiazepine hypnotic agent with an intermediate half-life of 12 to 15 hours." | 2.67 | Hypnotic efficacy of estazolam compared with flurazepam in outpatients with insomnia. ( Bremner, J; Cohn, JB; Ettinger, M; Wilcox, CS, 1991) |
"One hundred seven chronic insomniacs (41 men, 66 women; mean age, 37." | 2.67 | Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam. ( Judd, LL; Linnoila, M; Roehrs, T; Roth, T, 1990) |
" No marked adverse reactions were found in any area for any group." | 2.67 | Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs. ( Hauri, P; Kripke, D; Roehrs, T; Sateia, MJ, 1990) |
"Flurazepam-treated patients had a significantly more severe rating of adverse reactions than did placebo-treated patients." | 2.66 | Comparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia. ( Dominguez, RA; Goldstein, BJ; Jacobson, AF; Steinbook, RM, 1986) |
"Three groups of ten middle-aged insomniac patients were treated with placebo, flurazepam, or zopiclone for 12 consecutive days in a study designed to compare the residual daytime effects of long-acting flurazepam and short-acting zopiclone on a variety of cognitive and motor tasks." | 2.66 | Effects of flurazepam and zopiclone on the performance of chronic insomniac patients: a study of ethanol-drug interaction. ( Buck, L; Csima, A; Mamelak, M; Price, V; Smiley, A, 1987) |
"Triazolam, 0." | 2.66 | Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia. ( Bliwise, NG; Cohen, SA; Dement, WC; Roth, T; Seidel, WF, 1986) |
"Lormetazepam (1 and 2 mg) was tested against flurazepam (30 mg) and placebo in 60 patients (15 per treatment group) with initial, intermediate, or late insomnia." | 2.65 | Comparative study of lormetazepam and flurazepam in the treatment of insomnia. ( Melo de Paula, AJ, 1984) |
"Zopiclone is a new nonbenzodiazepine hypnotic, the recommended dose of which is 7." | 2.65 | Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age. ( Buytaert, G; Hoffman, G; Quadens, OP, 1983) |
"Triazolam (0." | 2.64 | Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs. ( Bowen, AJ, 1978) |
" The clinical implications are discussed with regard to the time of peak effectiveness of the drug, dosage recommendations and schedule, minimizing possible effects of the drug on daytime performance, and the rationale and method for using drug holidays in the treatment regimen." | 2.64 | Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs. ( Bixler, EO; Kales, A; Kales, JD; Scharf, M, 1976) |
"Flurazepam thus appears to be an effective hypnotic drug with the optimum dose for use in general practice being 15 mg at night." | 2.64 | A clinical and psychometric evaluation of flurazepam. ( Salkind, MR; Silverstone, T, 1975) |
"Triazolam 0-5 mg was found to be preferred and to be superior to placebo, flurazepam and chloral hydrate in the treatment of insomnia." | 2.64 | Preference studies of triazolam with standard hypnotics in out-patients with insomnia. ( Fabre, LF; Harris, RT; McLendon, DM, 1976) |
"Experimental sleep disturbance (model insomnia) was produced by intermittent white noise and the administration of 10 mg of methylphenidate (MPD)." | 2.64 | Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs. ( Honda, H; Okuma, T, 1978) |
" A significant dose-response curve was obtained with triazolam and flurazepam for some of the parameters." | 2.64 | Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo. ( Sunshine, A, 1975) |
"Up to 40% of adults have insomnia, with difficulty getting to sleep, early waking, or feeling unrefreshed on waking." | 2.44 | Insomnia in the elderly. ( Lilly, J; Montgomery, P, 2007) |
"Quazepam and flurazepam share pharmacokinetic properties that result in prevention of early-morning insomnia, daytime rebound anxiety, and withdrawal rebound insomnia." | 2.38 | Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics. ( Battista, D; Hilbert, JM, 1991) |
"Rebound insomnia, a worsening of sleep compared with pretreatment levels, has been reported upon discontinuation of short half-life benzodiazepine hypnotics." | 2.38 | Rebound insomnia: a critical review. ( Gillin, JC; Johnson, LC; Spinweber, CL, 1989) |
"Multiple etiologies for insomnia in the elderly have been described." | 2.38 | Insomnia in the elderly. ( Monane, M, 1992) |
"In general, chronic insomniacs showed all degrees of daytime alertness regardless of nocturnal sleep parameters." | 2.37 | Issues in the diagnosis and treatment of insomnia. ( Carskadon, M; Dement, W; Seidel, W, 1984) |
"Insomnia is defined and described with special attention to differentiating the subjective complaint and the laboratory assessment of objective sleep parameters." | 2.36 | Rational basis for the use of sleeping pills. ( Dement, WC, 1983) |
"Physician visits for insomnia account for only a small proportion of office visits but offer the opportunity for identification of underlying illnesses and for the prevention of associated problems." | 1.29 | Management of insomnia in office-based practice. National prevalence and therapeutic patterns. ( Brunton, SA; Radecki, SE, 1993) |
"We conclude that the evaluation of insomnia by nonpsychiatrists is often incomplete and that hypnotic drugs may be inappropriately prescribed by these physicians." | 1.28 | Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians. ( Bauwens, SF; Shorr, RI, 1992) |
"Two noncontinuous sleep disturbances, insomnia in the elderly and transient insomnia in young and middle-aged adults, are probably the most acceptable indications for the use of benzodiazepines." | 1.28 | Clinical uses and advantages of low doses of benzodiazepine hypnotics. ( Vogel, G, 1992) |
"Findings from a four-city study of the beneficial and adverse effects of hypnotics are reported." | 1.28 | The beneficial and adverse effects of hypnotics. ( Balter, MB; Uhlenhuth, EH, 1991) |
"Early morning insomnia, a significant increase in wakefulness during the final hours of drug nights, occurred after 1 or 2 weeks of nightly administration of benzodiazepine hypnotics with short elimination half-lives, when tolerance had begun to develop." | 1.27 | Early morning insomnia with rapidly eliminated benzodiazepines. ( Bixler, EO; Kales, A; Kales, JD; Soldatos, CR, 1983) |
"Zopiclone is a cyclopyrrolone derivative which exerts, in animal and man, an hypnotic activity comparable to that of flurazepam." | 1.26 | Efficacy and tolerance of zopiclone in insomniac geriatric patients. ( Deschenes, JP; Elie, R, 1982) |
"Zopiclone is a new nonbenzodiazepine hypnotic, the recommended dose of which is 7." | 1.26 | Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age. ( Buytaert, G; Hoffman, G; Quadens, OP, 1982) |
" Some loss of effectiveness was noted during long-term use of both doses of quazepam and, to a lesser extent, of flurazepam." | 1.26 | Quazepam and flurazepam: long-term use and extended withdrawal. ( Bixler, EO; Jacoby, J; Kales, A; Kales, JD; Soldatos, CR; Vela-Bueno, A, 1982) |
"Flurazepam hydrochloride was experimented on 43 patients aged 33-83 yr with various forms of insomnia over a period of 4 to 23 days (mean 11." | 1.25 | [Study of the tolerability and effectiveness of a new sleep-inducing preparation]. ( Brambilla, CM; Marras, F; Taglioretti, D, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 104 (75.36) | 18.7374 |
1990's | 31 (22.46) | 18.2507 |
2000's | 3 (2.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Montgomery, P | 1 |
Lilly, J | 1 |
Sylvestre, MP | 1 |
Abrahamowicz, M | 1 |
Waters, WF | 1 |
Hurry, MJ | 1 |
Binks, PG | 1 |
Carney, CE | 1 |
Lajos, LE | 1 |
Fuller, KH | 1 |
Betz, B | 1 |
Johnson, J | 1 |
Anderson, T | 1 |
Tucci, JM | 1 |
Fillingim, JM | 1 |
Dement, W | 4 |
Seidel, W | 4 |
Carskadon, M | 2 |
Muzet, A | 1 |
Johnson, LC | 8 |
Spinweber, CL | 3 |
De Anna, M | 1 |
Zucconi, M | 1 |
Baruzzi, A | 1 |
Cirignotta, F | 1 |
Gallassi, R | 1 |
Soverini, S | 1 |
Carskadon, MA | 1 |
Seidel, WF | 4 |
Greenblatt, DJ | 5 |
Dement, WC | 6 |
Kales, A | 10 |
Soldatos, CR | 6 |
Bixler, EO | 7 |
Kales, JD | 9 |
Elie, R | 3 |
Caillé, G | 1 |
Levasseur, FA | 1 |
Gareau, J | 1 |
Rickels, K | 1 |
Bliwise, D | 2 |
Karacan, I | 1 |
Mitler, M | 1 |
Roth, T | 8 |
Zorick, F | 3 |
Conell, LJ | 2 |
Berlin, RM | 2 |
Finucane, TE | 1 |
de Jonghe, F | 1 |
Ameling, EH | 1 |
Jonkers, F | 1 |
Folkers, C | 1 |
Schwarz, RV | 1 |
Wesnes, K | 1 |
Warburton, DM | 1 |
Feldbaum, JS | 1 |
Guilleminault, C | 1 |
Lindsley, JG | 2 |
Hartmann, EL | 1 |
Mitchell, W | 1 |
Quadens, OP | 2 |
Hoffman, G | 2 |
Buytaert, G | 2 |
Melo de Paula, AJ | 1 |
Hartmann, E | 2 |
Spinweber, C | 1 |
Swift, CG | 1 |
Swift, MR | 1 |
Hamley, J | 1 |
Stevenson, IH | 1 |
Crooks, J | 1 |
Pearlman, T | 1 |
Simmonds, K | 1 |
Kramer, M | 1 |
Schoen, LS | 1 |
Mendelson, WB | 5 |
Weingartner, H | 1 |
Garnett, D | 2 |
Gillin, JC | 3 |
Velasco, M | 1 |
Velasco, F | 1 |
Cepeda, C | 1 |
Romo, R | 1 |
Pérez-Toledo, MA | 1 |
Sanchez-Martinez, J | 1 |
Landa-Palos, DM | 1 |
Roehrs, T | 5 |
Kaffeman, M | 1 |
Sicklesteel, J | 1 |
Vela-Bueno, A | 2 |
Jacoby, J | 1 |
Deschenes, JP | 1 |
Halperin, JM | 1 |
Miller, D | 1 |
Iorio, LC | 1 |
Schneider, H | 1 |
Ladewig, D | 1 |
Labrecque, G | 1 |
Radecki, SE | 1 |
Brunton, SA | 1 |
Pollak, CP | 1 |
Perlick, D | 1 |
Linsner, JP | 1 |
Welton, DG | 1 |
Kesson, CM | 1 |
Gray, JM | 1 |
Lawson, DH | 1 |
Wang, RI | 1 |
Stockdale, SL | 1 |
Hieb, E | 1 |
Scharf, M | 1 |
Vogel, GW | 1 |
Barker, K | 1 |
Gibbons, P | 1 |
Thurmond, A | 1 |
Pines, A | 1 |
Rooney, JF | 1 |
Arenillas, L | 1 |
Salkind, MR | 1 |
Silverstone, T | 1 |
Wickstrom, E | 1 |
Fabre, LF | 2 |
McLendon, DM | 1 |
Harris, RT | 1 |
Rooke, KC | 1 |
Gross, L | 1 |
Pasigajen, V | 1 |
Metzler, C | 1 |
Bowen, AJ | 1 |
Sundaresan, PR | 1 |
Wardell, WM | 1 |
Weintraub, M | 1 |
Lasagna, L | 1 |
Solomon, F | 2 |
Medd, BH | 1 |
Nair, NP | 2 |
Schwartz, G | 2 |
Okuma, T | 1 |
Honda, H | 1 |
Church, MW | 1 |
Seales, DM | 1 |
Rossiter, VS | 1 |
Frost, JD | 1 |
DeLucchi, MR | 1 |
Cunningham, TA | 1 |
Sunshine, A | 1 |
Bussone, G | 1 |
Boiardi, A | 1 |
Lazzaroni, M | 1 |
Taglioretti, D | 1 |
Marras, F | 1 |
Brambilla, CM | 1 |
Bermejo, E | 1 |
Rey-Bellet, J | 1 |
Scharf, MB | 3 |
Babbini, M | 1 |
Torrielli, MV | 1 |
Strumia, E | 1 |
Gaiardi, M | 1 |
Bartoletti, M | 1 |
De Marchi, F | 1 |
Montplaisir, J | 1 |
Oswald, I | 1 |
MacPhail, I | 1 |
Ogilvie, WA | 1 |
Purvis, CR | 1 |
Anylan, WG | 1 |
Gillin, C | 1 |
Kripke, DF | 3 |
de Wet, BS | 1 |
Smith, JA | 1 |
Renshaw, DC | 1 |
Geyman, J | 1 |
Klett, CJ | 1 |
Vogel, G | 1 |
Monane, M | 1 |
Shorr, RI | 1 |
Bauwens, SF | 1 |
Walsh, JK | 1 |
Mahowald, MW | 1 |
Hilbert, JM | 1 |
Battista, D | 1 |
Roehrs, TA | 1 |
Cohn, JB | 1 |
Wilcox, CS | 1 |
Bremner, J | 1 |
Ettinger, M | 1 |
Roth, PB | 1 |
Dominguez, RA | 2 |
Ware, JC | 1 |
Balter, MB | 1 |
Uhlenhuth, EH | 1 |
Lavoie, G | 1 |
Bourgouin, J | 1 |
Le Morvan, P | 2 |
Chernik, DA | 4 |
Sateia, MJ | 2 |
Dimitri, R | 1 |
Thavundayil, JX | 1 |
Ponciano, E | 1 |
Freitas, F | 1 |
Camara, J | 1 |
Faria, M | 1 |
Barreto, M | 1 |
Hindmarch, I | 1 |
Kanitra, L | 1 |
Linnoila, M | 4 |
Judd, LL | 3 |
Hauri, P | 4 |
Kripke, D | 1 |
Chen, D | 1 |
Ellinwood, E | 3 |
Moskowitz, H | 2 |
Ancoli-Israel, S | 1 |
McAdams, LA | 1 |
Marsh, G | 1 |
Bergener, M | 1 |
Gola, R | 1 |
Hesse, C | 1 |
Mamelak, M | 2 |
Csima, A | 2 |
Buck, L | 2 |
Price, V | 2 |
Sussman, N | 1 |
Jacoby, JA | 1 |
Beauchair, L | 1 |
Fontaine, R | 1 |
Lanaia, F | 1 |
Scrofani, A | 1 |
Biondi, R | 1 |
Rodolico, F | 1 |
Conway, W | 1 |
Cohen, SA | 2 |
Bliwise, NG | 2 |
Goldstein, BJ | 1 |
Jacobson, AF | 1 |
Steinbook, RM | 1 |
Baker, MI | 1 |
Oleen, MA | 1 |
McClure, DJ | 1 |
Walsh, J | 1 |
Chang, H | 1 |
Olah, A | 1 |
Wilson, R | 1 |
Pecknold, JC | 1 |
Smiley, A | 1 |
Fleming, JA | 1 |
Rungta, K | 1 |
Isomura, T | 1 |
McMillan, MJ | 1 |
Miller, RR | 1 |
Meyer, JA | 1 |
Kurland, KZ | 1 |
Itil, TM | 1 |
Polvan, N | 1 |
Egilmez, S | 1 |
Saletu, B | 1 |
Marasa, J | 1 |
Tan, TL | 1 |
Hussey, HH | 1 |
Swanson, DA | 1 |
Heimann, H | 1 |
Schmocker, AM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Hydroxychloroquine Exposure in Systemic Lupus Erythematosus (SLE)[NCT03802188] | 3,700 participants (Anticipated) | Observational | 2018-05-09 | Recruiting | |||
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome[NCT00540254] | Phase 1/Phase 2 | 24 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
A Phase IV 3-Way Double-blind, Randomized, Crossover Study to Compare the Awakening Threshold Effects (Responsivity) of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs[NCT03312517] | Phase 4 | 12 participants (Actual) | Interventional | 2018-04-15 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Subjects will be awakened during the night to auditory awakening tones. (NCT03312517)
Timeframe: 2.5 hours post-dose of each Study Drug administration
Intervention | decibels (db) (Mean) |
---|---|
Suvorexant 10mg | 74.17 |
Suvorexant 20mg | 83.75 |
Placebo Oral Capsule | 79.17 |
19 reviews available for flurazepam and Sleep Initiation and Maintenance Disorders
Article | Year |
---|---|
Insomnia in the elderly.
Topics: Aged; Cognitive Behavioral Therapy; Flurazepam; Humans; Risk Factors; Sleep; Sleep Initiation and Ma | 2007 |
Clinical trials of hypnotics.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li | 1983 |
Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Dose-Response Relationship, Drug; Fl | 1983 |
Rational basis for the use of sleeping pills.
Topics: Anxiety; Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Kinetics; Sleep; Sleep Initia | 1983 |
Issues in the diagnosis and treatment of insomnia.
Topics: Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Psychomotor Performance; Respiration; | 1984 |
[Insomnia and its treatment].
Topics: Amphetamines; Apnea; Behavior Therapy; Flurazepam; Habits; Humans; Hypnotics and Sedatives; Mental D | 1977 |
The why and how of hypnotic drugs.
Topics: Benzodiazepines; Female; Flurazepam; Humans; Hypnotics and Sedatives; Male; Middle Aged; Sleep; Slee | 1979 |
Management of insomnia.
Topics: Antidepressive Agents, Tricyclic; Flurazepam; Humans; Hypnotics and Sedatives; Medical History Takin | 1979 |
Pharmacology of benzodiazepine hypnotics.
Topics: Benzodiazepines; Flurazepam; Humans; Memory; Receptors, GABA-A; Sleep; Sleep Initiation and Maintena | 1992 |
Review of triazolam data.
Topics: Age Factors; Aged; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Ph | 1992 |
Insomnia in the elderly.
Topics: Adult; Age Factors; Aged; Aging; Benzodiazepines; Flurazepam; Humans; Middle Aged; Patient Education | 1992 |
Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Cricetinae; Flurazepam; Humans; Hy | 1991 |
A review of the safety profiles of benzodiazepine hypnotics.
Topics: Aged; Anti-Anxiety Agents; Benzodiazepines; Central Nervous System; Flurazepam; Half-Life; Humans; H | 1991 |
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
Topics: Chronic Disease; Double-Blind Method; Flurazepam; Humans; Long-Term Care; Midazolam; Psychomotor Per | 1990 |
Rebound insomnia: a critical review.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Sleep Stages; S | 1989 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D | 1985 |
Pharmacological effects of sedative-hypnotics, narcotic analgesics, and alcohol during sleep.
Topics: Adult; Aged; Anti-Anxiety Agents; Ethanol; Female; Flurazepam; Humans; Hypnotics and Sedatives; Male | 1985 |
Behavioral side effects of benzodiazepine hypnotics.
Topics: Amnesia; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Flurazepam; Humans; Hypnotics and Sedatives; | 1985 |
Drug therapy reviews. Rational use of psychotropic drugs. I. Hypnotics.
Topics: Barbiturates; Chlorates; Dose-Response Relationship, Drug; Dreams; Drug Interactions; Drug Synergism | 1974 |
64 trials available for flurazepam and Sleep Initiation and Maintenance Disorders
Article | Year |
---|---|
Behavioral and hypnotic treatments for insomnia subtypes.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Electroencephalography; Electromyography; Female | 2003 |
Double-blind evaluation of temazepam, flurazepam, and placebo in geriatric insomniacs.
Topics: Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Flurazepam; Humans | 1982 |
[Double-blind comparison of lormetazepam and flurazepam in the treatment of patients with insomnia].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Double-Blin | 1982 |
Daytime carryover of triazolam and flurazepam in elderly insomniacs.
Topics: Aged; Anti-Anxiety Agents; Arousal; Clinical Trials as Topic; Emotions; Female; Flurazepam; Humans; | 1982 |
Comparative hypnotic activity of single doses of loprazolam, flurazepam, and placebo.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Clinical Trials as Topic; Doub | 1983 |
Clinical trials of hypnotics.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Flurazepam; Half-Li | 1983 |
Flurazepam and temazepam in the treatment of insomnia in a general hospital population.
Topics: Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Female; Flurazepam; | 1984 |
A comparison of temazepam and flurazepam in terms of sleep quality and residual changes in performance.
Topics: Adult; Anti-Anxiety Agents; Attention; Cognition; Discrimination Learning; Female; Flicker Fusion; F | 1984 |
Selectivity in response to L-tryptophan among insomniac subjects: a preliminary report.
Topics: Adolescent; Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Flurazepam; Humans; Hypn | 1983 |
Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age.
Topics: Azabicyclo Compounds; Clinical Trials as Topic; Double-Blind Method; Electroencephalography; Electro | 1983 |
Comparative study of lormetazepam and flurazepam in the treatment of insomnia.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relati | 1984 |
Chronic insomnia: effects of tryptophan, flurazepam, secobarbital, and placebo.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Flurazepam; Humans; Male; Placebos; Secoba | 1983 |
Nighttime and daytime efficacy of flurazepam and oxazepam in chronic insomnia.
Topics: Chronic Disease; Circadian Rhythm; Electroencephalography; Electromyography; Electrooculography; Flu | 1984 |
A clinical study of flurazepam.
Topics: Clinical Trials as Topic; Cognition; Drug Evaluation; Electroencephalography; Flurazepam; Humans; Ps | 1982 |
Effect of a new thienodiazepine (We-941) on sleep patterns of normal and insomniac subjects.
Topics: Adolescent; Adult; Azepines; Clinical Trials as Topic; Flurazepam; Humans; Hypnotics and Sedatives; | 1981 |
A new thienodiazepine, brotizolam, for the treatment of insomnia.
Topics: Adult; Azepines; Chemical Phenomena; Chemistry; Double-Blind Method; Flurazepam; Humans; Middle Aged | 1982 |
Effects of flurazepam and zolpidem on the perception of sleep in normal volunteers.
Topics: Adult; Cognition; Female; Flurazepam; Humans; Hypnotics and Sedatives; Male; Placebos; Polysomnograp | 1995 |
Effects of flurazepam and zolpidem on the perception of sleep in insomniacs.
Topics: Adult; Arousal; Electroencephalography; Female; Flurazepam; Humans; Hypnotics and Sedatives; Male; P | 1995 |
Benzodiazepine drugs in general medical patients.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Drug Evaluation; Drug Prescriptions; Flurazepam; Huma | 1976 |
Hypnotic efficacy of lorazepam and flurazepam.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Flurazepam; Humans; Lorazepam; Male; Sleep; Sleep Ini | 1976 |
Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Electroencephalography; Electromyography; Electroocul | 1976 |
A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Female; Flurazepam; Humans; Male; Middle Aged; | 1976 |
Flurazepam ('Dalmane') in the treatment of insomnia in patients with respiratory disorders.
Topics: Aged; Amobarbital; Anti-Anxiety Agents; Clinical Trials as Topic; Dreams; Flurazepam; Humans; Male; | 1976 |
A clinical and psychometric evaluation of flurazepam.
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Drug Evaluation; Female; Flurazepam; Humans; Male; Mo | 1975 |
[Flunitrazepam and flurazepam. A comparative study].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Drug Evaluation; Female; Flunitrazepam; Flurazepam; Hu | 1976 |
Preference studies of triazolam with standard hypnotics in out-patients with insomnia.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Chloral Hydrate; Clinical Trials as Topic; Double-Blin | 1976 |
Multiclinic double-blind comparison of triazolam and flurazepam for seven nights in outpatients with insomnia.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Drug Ev | 1977 |
Comparative efficacy of triazolam, flurazepam and placebo in out-patients insomniacs.
Topics: Adult; Anti-Anxiety Agents; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; | 1978 |
Methodology for demonstrating sustained efficacy of hypnotics: a comparative study of triazolam and flurazepam.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Flurazepam; Humans; Middl | 1979 |
Model insomnia, noise, and methylphenidate, used for the evaluation of hypnotic drugs.
Topics: Adult; Drug Evaluation; Electroencephalography; Flurazepam; Humans; Hypnotics and Sedatives; Male; M | 1978 |
Insomnia in the elderly: treatment with flurazepam hydrochloride.
Topics: Aged; Female; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep, R | 1979 |
Comparison of the hypnotic activity of triazolam, flurazepam hydrochloride, and placebo.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzazepines; Chlorobenzenes; Clinical Trials as Topic; Dose-Respo | 1975 |
Flurazepam (Dalmane).
Topics: Anti-Anxiety Agents; Clinical Trials as Topic; Flurazepam; Half-Life; Humans; Sleep Initiation and M | 1975 |
Effectiveness of hypnotic drugs with prolonged use: flurazepam and pentobarbital.
Topics: Adult; Anti-Anxiety Agents; Clinical Trials as Topic; Drug Evaluation; Electroencephalography; Flura | 1975 |
Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings.
Topics: Aged; Animals; Anti-Anxiety Agents; Benzodiazepinones; Blood Pressure; Cats; Clinical Trials as Topi | 1975 |
Comparison of diazepam and flurazepam in the treatment of insomnia in general practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Capsules; Clinical Trials as Topic; Diazepam; Double- | 1979 |
A clinical study of insomnia.
Topics: Adult; Aged; Anxiety Disorders; Clinical Trials as Topic; Depression; Doxepin; Drug Therapy, Combina | 1975 |
Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Anxiety Agents; Benzodiazepines; Circa | 1991 |
Hypnotic efficacy of estazolam compared with flurazepam in outpatients with insomnia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Double-Blind Method; Estazolam; Female; Flurazepam; Humans | 1991 |
Estazolam and flurazepam: a multicenter, placebo-controlled comparative study in outpatients with insomnia.
Topics: Ambulatory Care; Anti-Anxiety Agents; Double-Blind Method; Drug Evaluation; Estazolam; Flurazepam; H | 1990 |
Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal.
Topics: Adult; Azabicyclo Compounds; Double-Blind Method; Female; Flurazepam; Humans; Hypnotics and Sedative | 1990 |
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: an introduction.
Topics: Chronic Disease; Double-Blind Method; Flurazepam; Humans; Long-Term Care; Midazolam; Psychomotor Per | 1990 |
A dose-range finding study of zopiclone in insomniac patients.
Topics: Adolescent; Adult; Aged; Arousal; Azabicyclo Compounds; Dose-Response Relationship, Drug; Double-Bli | 1990 |
A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients.
Topics: Adolescent; Adult; Arousal; Attention; Azabicyclo Compounds; Body Weight; Double-Blind Method; Drug | 1990 |
Effects of flurazepam and midazolam on sleep and next-day performance in chronic insomniacs: report of a multicenter study.
Topics: Flurazepam; Humans; Midazolam; Sleep; Sleep Initiation and Maintenance Disorders | 1990 |
Sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: methodology.
Topics: Adult; Affect; Arousal; Attention; Electroencephalography; Female; Flurazepam; Half-Life; Humans; Ma | 1990 |
Characteristics of chronic insomniacs examined in a multicenter 14-day study of flurazepam and midazolam.
Topics: Adult; Affect; Arousal; Electroencephalography; Female; Flurazepam; Humans; Male; Midazolam; Middle | 1990 |
Clinical safety of flurazepam and midazolam during 14-day use in chronic insomniacs.
Topics: Adult; Double-Blind Method; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; Sleep Apnea Sy | 1990 |
A multicenter study of sleep, performance, and plasma levels in chronic insomniacs during 14-day use of flurazepam and midazolam: executive summary.
Topics: Adult; Affect; Arousal; Chronic Disease; Double-Blind Method; Flurazepam; Humans; Midazolam; Psychom | 1990 |
Sleep evaluation in chronic insomniacs during 14-day use of flurazepam and midazolam.
Topics: Adult; Arousal; Dose-Response Relationship, Drug; Electroencephalography; Female; Flurazepam; Humans | 1990 |
Psychomotor performance in chronic insomniacs during 14-day use of flurazepam and midazolam.
Topics: Adult; Arousal; Attention; Dose-Response Relationship, Drug; Female; Flurazepam; Humans; Male; Midaz | 1990 |
Cognitive performance and mood in patients with chronic insomnia during 14-day use of flurazepam and midazolam.
Topics: Adult; Affect; Arousal; Attention; Dose-Response Relationship, Drug; Drug Administration Schedule; F | 1990 |
Plasma concentrations of flurazepam and midazolam in chronic insomniacs during 14-day use and their relationship to therapeutic effects and next-day performance and mood.
Topics: Adult; Arousal; Attention; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; F | 1990 |
A multicenter 14-day study of flurazepam and midazolam in chronic insomniacs: general discussion and conclusions.
Topics: Arousal; Attention; Double-Blind Method; Female; Flurazepam; Humans; Male; Midazolam; Middle Aged; P | 1990 |
The influence of age-dependent pharmacokinetics on the pharmacodynamics of hypnotic drugs: comparison of two hypnotics with different half-lives.
Topics: Aged; Arousal; Azabicyclo Compounds; Double-Blind Method; Female; Flurazepam; Half-Life; Hospitaliza | 1989 |
A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly.
Topics: Aged; Arousal; Attention; Azepines; Clinical Trials as Topic; Discrimination Learning; Double-Blind | 1989 |
Rebound insomnia and elimination half-life: assessment of individual subject response.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Dose-Response Relationship, D | 1985 |
Buspirone: an anxiolytic without sedative effect.
Topics: Adult; Anti-Anxiety Agents; Buspirone; Chronic Disease; Clinical Trials as Topic; Double-Blind Metho | 1985 |
Comparative efficacy of estazolam, flurazepam, and placebo in outpatients with insomnia.
Topics: Adult; Aged; Ambulatory Care; Anti-Anxiety Agents; Clinical Trials as Topic; Double-Blind Method; Dr | 1986 |
Comparison of lorazepam and flurazepam as hypnotic agents in chronic insomniacs.
Topics: Adult; Arousal; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Electroencephalograp | 1988 |
Effects of flurazepam and zopiclone on the performance of chronic insomniac patients: a study of ethanol-drug interaction.
Topics: Adult; Azabicyclo Compounds; Drug Interactions; Ethanol; Female; Flurazepam; Humans; Hypnotics and S | 1987 |
Dose-related effects of triazolam and flurazepam on a circadian rhythm insomnia.
Topics: Adult; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Flurazepam; Humans; | 1986 |
Controlled evaluation of flurazepam hydrochloride, a new nonbarbiturate hypnotic.
Topics: Adult; Benzazepines; Clinical Trials as Topic; Flurazepam; Humans; Hypnotics and Sedatives; Middle A | 1973 |
A double-blind evaluation of a new hypnotic--flurazepam hydrochloride.
Topics: Adult; Aged; Amobarbital; Benzazepines; Clinical Trials as Topic; Female; Flurazepam; Humans; Hypnot | 1973 |
58 other studies available for flurazepam and Sleep Initiation and Maintenance Disorders
Article | Year |
---|---|
Flexible modeling of the cumulative effects of time-dependent exposures on the hazard.
Topics: Accidental Falls; Cohort Studies; Dose-Response Relationship, Drug; Flurazepam; Humans; Hypnotics an | 2009 |
Choice of benzodiazepines.
Topics: Aged; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Diazepam; Flurazepam; Half-Life; Humans; Liver | 1981 |
Daytime alertness, insomnia, and benzodiazepines.
Topics: Adult; Anti-Anxiety Agents; Arousal; Benzodiazepines; Double-Blind Method; Flurazepam; Humans; Loraz | 1982 |
Benzodiazepine hypnotics increase heart rate during sleep.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Flurazepam; Heart Rate; Humans; Male; Sleep; Sleep | 1982 |
Early morning insomnia with rapidly eliminated benzodiazepines.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Half-Life; Humans; Midazolam; Sleep; Sleep Initiat | 1983 |
Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam.
Topics: Adult; Anti-Anxiety Agents; Arousal; Double-Blind Method; Female; Flurazepam; Humans; Male; Sleep In | 1983 |
Withdrawal after substitution of a short-acting for a long-acting benzodiazepine.
Topics: Anti-Anxiety Agents; Anxiety; Chronic Disease; Delayed-Action Preparations; Diazepam; Flurazepam; Ha | 1983 |
Flurazepam and other benzodiazepines.
Topics: Anti-Anxiety Agents; Drug Utilization; Flurazepam; Humans; Sleep Initiation and Maintenance Disorder | 1984 |
Inadvertent benzodiazepine withdrawal.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Male; Middle Aged; Sleep Initiation and Maintenance Disorde | 1984 |
Sleep spindle and delta changes during chronic use of a short-acting and a long-acting benzodiazepine hypnotic.
Topics: Adult; Anti-Anxiety Agents; Brain; Double-Blind Method; Electroencephalography; Female; Flurazepam; | 1983 |
[Benzodiazepines: effects on sleep and on attention capacity the following day. Long-term study administration of lormetazepam and flurazepam].
Topics: Adult; Anti-Anxiety Agents; Attention; Benzodiazepines; Female; Flurazepam; Humans; Lorazepam; Male; | 1984 |
Side-effect 'tolerance' in elderly long-term recipients of benzodiazepine hypnotics.
Topics: Aged; Biotransformation; Dose-Response Relationship, Drug; Drug Tolerance; Female; Flurazepam; Human | 1984 |
Withdrawal symptoms after long-term treatment with flurazepam.
Topics: Anxiety Disorders; Depressive Disorder; Diazepam; Flurazepam; Humans; Sleep Initiation and Maintenan | 1984 |
A good night's sleep may be in store for patients with COPD.
Topics: Flurazepam; Humans; Lung Diseases, Obstructive; Male; Sleep Initiation and Maintenance Disorders | 1984 |
Problems in the use of long-acting hypnotics in older patients.
Topics: Age Factors; Aged; Ataxia; Flurazepam; Hospitalization; Humans; Motor Skills; Sleep Initiation and M | 1984 |
Withdrawal symptoms after long-term treatment with therapeutic doses of flurazepam: a case report.
Topics: Adult; Chronic Disease; Flurazepam; Humans; Male; Sleep Initiation and Maintenance Disorders; Substa | 1983 |
Flurazepam for short-term treatment of complaints of insomnia.
Topics: Adult; Female; Flurazepam; Humans; Male; Sleep Initiation and Maintenance Disorders; Sleep Stages | 1982 |
Quazepam and flurazepam: long-term use and extended withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Drug Evaluation; Flurazepam; Half-Life; Humans; Middle | 1982 |
Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age.
Topics: Azabicyclo Compounds; Double-Blind Method; Drug Evaluation; Electroencephalography; Female; Flurazep | 1982 |
Efficacy and tolerance of zopiclone in insomniac geriatric patients.
Topics: Aged; Azabicyclo Compounds; Double-Blind Method; Drug Evaluation; Female; Flurazepam; Humans; Hypnot | 1982 |
Sleep-inducing effects of three hypnotics in a new model of insomnia in rats.
Topics: Animals; Disease Models, Animal; Electroencephalography; Electromyography; Flurazepam; Humans; Hypno | 1981 |
Flurazepam-induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes.
Topics: Adult; Flurazepam; Humans; Male; Placebos; Sleep Apnea Syndromes; Sleep Initiation and Maintenance D | 1981 |
[Dalmadorm, an almost ideal hypnotic].
Topics: Drug Evaluation; Drug Interactions; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation an | 1980 |
[Does a rebound insomnia following benzodiazepine administration exist?].
Topics: Benzodiazepines; Diazepam; Flunitrazepam; Flurazepam; Humans; Nitrazepam; Sleep Initiation and Maint | 1980 |
[Between the two...].
Topics: Aged; Flurazepam; Humans; Hypnotics and Sedatives; Sleep; Sleep Initiation and Maintenance Disorders | 1980 |
Management of insomnia in office-based practice. National prevalence and therapeutic patterns.
Topics: Adolescent; Adult; Aged; Data Collection; Female; Flurazepam; Humans; Male; Medicine; Middle Aged; P | 1993 |
Sleep and motor activity of community elderly who frequently use bedtime medications.
Topics: Aged; Circadian Rhythm; Diazepam; Drug Administration Schedule; Female; Flurazepam; Humans; Hypnotic | 1994 |
When "my heart stood still".
Topics: Arrhythmias, Cardiac; Diuretics; Flurazepam; Heart Arrest; Humans; Pacemaker, Artificial; Sleep Init | 1993 |
The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice.
Topics: Adult; Aged; Anti-Anxiety Agents; Barbiturates; Diphenhydramine; Drug Combinations; Family Practice; | 1976 |
[Drugs against insomnia].
Topics: Barbiturates; Chloral Hydrate; Diphenhydramine; Flurazepam; Glutethimide; Humans; Hypnotics and Seda | 1978 |
Sleeping pills.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders | 1979 |
Sleeping pills and insomnia.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Substance-Relat | 1979 |
[Comparison of the hypnotic activity of triazolam and flurazepam].
Topics: Adult; Anti-Anxiety Agents; Evaluation Studies as Topic; Female; Flurazepam; Humans; Male; Middle Ag | 1979 |
Auditory arousal thresholds of good sleepers and poor sleepers with and without flurazepam.
Topics: Acoustic Stimulation; Adult; Arousal; Auditory Threshold; Double-Blind Method; Flurazepam; Humans; M | 1979 |
Letter: Use of hypnotics.
Topics: Animals; Anti-Anxiety Agents; Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation and Main | 1975 |
Letter: Adverse reaction to flurazepam.
Topics: Aged; Anti-Anxiety Agents; Flurazepam; Humans; Male; Psychoses, Substance-Induced; Sleep Initiation | 1975 |
[Controlled clinical trial of a new benzodiazepine (Ro 5-6901) active on sleep disorders].
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Drug Evaluation; Female; Flurazepam; Humans; Middle Ag | 1975 |
[Study of the tolerability and effectiveness of a new sleep-inducing preparation].
Topics: Adult; Aged; Anti-Anxiety Agents; Female; Flurazepam; Humans; Male; Middle Aged; Sleep Initiation an | 1975 |
[Comparative study on the hypnotic effect of flurazepam and heptabarbital].
Topics: Adult; Age Factors; Aged; Anti-Anxiety Agents; Barbiturates; Flurazepam; Humans; Mental Disorders; M | 1975 |
Sleeping pills and insomnia.
Topics: Flurazepam; Humans; Hypnotics and Sedatives; Sleep Initiation and Maintenance Disorders | 1979 |
Sleeping pills and insomnia.
Topics: Flurazepam; Humans; Hypnotics and Sedatives; Risk; Sleep Initiation and Maintenance Disorders | 1979 |
Which benzodiazepine, why and how?
Topics: Flurazepam; Humans; Nitrazepam; Sleep; Sleep Initiation and Maintenance Disorders | 1979 |
Editorial: Evaluation and management of insomnia.
Topics: Flurazepam; Humans; Sleep Initiation and Maintenance Disorders | 1975 |
Clinical uses and advantages of low doses of benzodiazepine hypnotics.
Topics: Adult; Aged; Amnesia; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedul | 1992 |
Diagnosis and treatment of outpatient insomnia by psychiatric and nonpsychiatric physicians.
Topics: Disease; Drug Prescriptions; Drug Utilization; Female; Flurazepam; General Surgery; Humans; Internal | 1992 |
Avoiding the blanket approach to insomnia. Targeted therapy for specific causes.
Topics: Anti-Anxiety Agents; Benzodiazepines; Chronic Disease; Diagnosis, Differential; Estazolam; Flurazepa | 1991 |
The beneficial and adverse effects of hypnotics.
Topics: Adolescent; Adult; Aged; Attitude to Health; Benzodiazepines; Data Collection; Drug Prescriptions; E | 1991 |
Putting benzodiazepine hypnotics into proper therapeutic perspective.
Topics: Anti-Anxiety Agents; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Temazepam; Tria | 1985 |
Benzodiazepines: half-life and daytime sleepiness.
Topics: Anti-Anxiety Agents; Circadian Rhythm; Flurazepam; Half-Life; Humans; Oxazepam; Sleep; Sleep Initiat | 1985 |
[Efficacy and tolerance of triazolam compared with flurazepam in patients with insomnia].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Drug Tolerance; Female; Flurazepam; Humans; Male; Middle Age | 1985 |
The use of benzodiazepine hypnotics in the elderly.
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Canada; Drug Interactions; Drug Prescriptions; Dru | 1988 |
Withdrawal regimen for triazolam-dependent patients.
Topics: Diazepam; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndr | 1986 |
Quazepam: sleep laboratory studies of effectiveness and withdrawal.
Topics: Anti-Anxiety Agents; Benzodiazepines; Flurazepam; Humans; Sleep Initiation and Maintenance Disorders | 1985 |
Anxiolytic effects of a new triazolobenzodiazepine, U-31,889.
Topics: Adult; Animals; Anxiety; Behavior, Animal; Benzodiazepinones; Blood Circulation; Central Nervous Sys | 1973 |
Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependence.
Topics: Adult; Age Factors; Aged; Amobarbital; Chloral Hydrate; Chronic Disease; Dreams; Drug Therapy, Combi | 1974 |
Editorial: Insomnia.
Topics: Apnea; Chronic Disease; Flurazepam; Humans; Hypnotics and Sedatives; Iatrogenic Disease; Male; Middl | 1974 |
[Sleep disorders, their origin and treatment].
Topics: Age Factors; Antidepressive Agents; Depression; Flurazepam; Humans; Intracranial Arteriosclerosis; M | 1974 |
Two more benzodiazepines: clorazepate and flurazepam.
Topics: Anti-Anxiety Agents; Benzazepines; Carboxylic Acids; Clorazepate Dipotassium; Electroencephalography | 1974 |